Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats

Based on transcriptomic, proteomic, and metabolomic analyses, we developed an strategy to explore the key targets and mechanisms of Astragaloside IV treatment for cerebral ischemia in rats to obtain a compound–reaction–enzyme–gene network.